人工心臓弁の世界市場：機械式心臓弁、経カテーテル心臓弁、組織心臓弁...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Integrated Ecosystem of Prosthetic Heart Valve Market
2.1.1 Top-Down Approach
2.1.2 Bottom-Up Approach
2.1.3 Demand-Side Approach
2.2 Product Matrix
2.3 Assumptions

3 Executive Summary (Page No. – 24)

4 Market Overview (Page No. – 26)
4.1 Market: Comparison With Cardiac Medical Devices (Parent Market)
4.2 Market Drivers and Inhibitors
4.3 Key Market Dynamics

5 Prosthetic Heart Valve Market, By Type (Page No. – 30)
5.1 Introduction
5.2 Mechanical Heart Valve
5.3 Tissue Heart Valve
5.4 Transcatheter Heart Valve

6 Prosthetic Heart Valve Market, By Geography (Page No. – 37)
6.1 Introduction
6.2 Americas
6.2.1 By Country
6.2.1.1 U.S.
6.2.1.2 Canada
6.2.1.3 Brazil
6.2.1.4 Mexico
6.2.1.5 Argentina
6.2.1.6 Colombia
6.2.1.7 Chile
6.2.1.8 Paraguay
6.2.1.9 Uruguay
6.2.2 By Type
6.3 Europe
6.3.1 By Country
6.3.1.1 Germany
6.3.1.2 France
6.3.1.3 U.K.
6.3.1.4 Spain
6.3.1.5 Italy
6.3.1.6 Netherlands
6.3.1.7 Turkey
6.3.1.8 Belgium
6.3.1.9 Switzerland
6.3.1.10 Russia
6.3.1.11 Denmark
6.3.2 By Type
6.4 Asia-Pacific (APAC)
6.4.1 By Country
6.4.1.1 Japan
6.4.1.2 China
6.4.1.3 Australia
6.4.1.4 India
6.4.1.5 Republic of Korea
6.4.1.6 New Zealand
6.4.1.7 Singapore
6.4.1.8 Thailand
6.4.1.9 Malaysia
6.4.1.10 Vietnam
6.4.1.11 Taiwan
6.4.1.12 Indonesia
6.4.2 By Type
6.5 Middle East Africa (MEA)
6.5.1 By Country
6.5.1.1 Egypt
6.5.1.2 Saudi Arabia
6.5.1.3 United Arab Emirates (UAE)
6.5.1.4 South Africa
6.5.1.5 Libya
6.5.1.6 Algeria
6.5.1.7 Kenya
6.5.1.8 Kuwait
6.5.1.9 Jordan
6.5.1.10 Sudan
6.5.1.11 Morocco
6.5.1.12 Tunisia
6.5.1.13 Israel
6.5.1.14 Zimbabwe
6.5.1.15 Mauritius
6.5.1.16 Oman
6.5.2 By Type

7 Competitive Landscape (Page No. – 114)
7.1 Company Share Analysis : Prosthetic Heart Valves Market
7.1.1 U.S.
7.1.2 Canada
7.1.3 Brazil
7.1.4 Germany
7.1.5 France
7.1.6 U.K.
7.1.7 China
7.1.8 India
7.1.9 Japan
7.2 New Product Launches
7.3 Mergers and Acquisitions
7.4 Collaborations, Joint Agreements & Expansions, Partnership
7.5 Approvals, Alliances, Relocations & Licensing, and New Brand Strategy

8 Company Profiles (Page No. – 125)
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 Abbott Laboratories
8.2 Boston Scientific Corporation
8.3 Medtronic
8.4 ST. Jude Medical, Inc.
8.5 Edwards Lifesciences Corporation
8.6 Sorin S.P.A.
8.7 Neovasc Inc.
8.8 Colibri Heart Valve, LLC
8.9 On-X Life Technologies Inc.
8.10 Symetis
8.11 Cytograft
8.12 Jenavalve Technology

*Details on Overview, Financials, Product & Services, Strategy, and Developments Might Not Be Captured in Case of Unlisted Companies.

9 Appendix (Page No. – 145)
9.1 Customization Options
9.1.1 Product Analysis
9.1.2 Surgeons/ Doctors Perception Analysis
9.1.3 Regulatory Framework
9.1.4 Competitive Intelligence
9.2 Introducing RT: Real-Time Market Intelligence
9.3 Related Reports